Inventor · disambiguated record
Desmond Mascarenhas
Also filed as: MASCARENHAS DESMOND · MASCARENHAS DESMOND D
33 granted patents·17 pending applications·1,100 citations·filing 1993–2024
98Inventor score
Top patents by PatentIndex Score
50 records- 0195US5824467AMethods for predicting drug responseCELTRIX PHARMA·Filed 1997·Granted Oct 20, 1998·155 cites·6 claims
- 0292US7213032B2System and method for anonymous transaction in a data network and classification of individuals without knowing their real identityPROTIGEN INC·Filed 2001·Granted May 1, 2007·98 cites·15 claims
- 0392US6887851B2IGF-binding protein-derived peptideBIOEXPERTISE LLC·Filed 2002·Granted May 3, 2005·33 cites·13 claims
- 0490US8010400B2System and method for using psychological significance pattern information for matching with target informationPROTIGEN INC·Filed 2006·Granted Aug 30, 2011·21 cites·30 claims
- 0590US6914049B2IGF-binding protein-derived peptide or small moleculeBIOEXPERTISE LLC·Filed 2003·Granted Jul 5, 2005·33 cites·27 claims
- 0690US5914254AExpression of fusion polypeptides transported out of the cytoplasm without leader sequencesCELTRIX PHARMA·Filed 1997·Granted Jun 22, 1999·118 cites·29 claims
- 0789US6861406B2IGF-binding protein-derived peptideBIOEXPERTISE LLC·Filed 2002·Granted Mar 1, 2005·34 cites·5 claims
- 0889US6087090AMethods for predicting drug responseCELTRIX PHARMA·Filed 1998·Granted Jul 11, 2000·89 cites·19 claims
- 0986US7611893B2Metal-binding therapeutic peptidesONTHERIX INC·Filed 2007·Granted Nov 3, 2009·9 cites·24 claims
- 1085US7662624B2Metal-binding therapeutic peptidesONTHERIX INC·Filed 2008·Granted Feb 16, 2010·6 cites·32 claims
- 1185US5693607AUses of TGF-β receptor fragment as a therapeutic agentFiled 1994·Granted Dec 2, 1997·70 cites·5 claims
- 1285US5563046AFusion polypeptides and proteinsCELTRIX PHARMA·Filed 1993·Granted Oct 8, 1996·52 cites·25 claims
- 1385US5470727AChromosomal expression of non-bacterial genes in bacterial cellsCELTRIX PHARMA·Filed 1993·Granted Nov 28, 1995·69 cites·1 claims
- 1484US7618816B2Metal-binding therapeutic peptidesONTHERIX INC·Filed 2006·Granted Nov 17, 2009·7 cites·12 claims
- 1584US7162432B2System and method for using psychological significance pattern information for matching with target informationPROTIGEN INC·Filed 2001·Granted Jan 9, 2007·39 cites·22 claims
- 1680US6808393B2Interactive assessment toolPROTIGEN INC·Filed 2001·Granted Oct 26, 2004·21 cites·5 claims
- 1778US6015786AMethod for increasing sex steroid levels using IGF or IGF/IGFBP-3CELTRIX PHARMA·Filed 1997·Granted Jan 18, 2000·33 cites·6 claims
- 1877US2024285540A1Functional therapeutic index in the treatment of peripheral immune dysfunctionMASCARENHAS DESMOND·Filed 2024·Application pending·0 cites
- 1975US5861273AChromosomal expression of heterologous genes in bacterial cellsCELTRIX PHAMRACEUTICALS INC·Filed 1995·Granted Jan 19, 1999·45 cites·12 claims
- 2075US5830706APolypeptide fusions to polypeptides of the beta-trefoil fold structural familyCELTRIX PHARMA·Filed 1995·Granted Nov 3, 1998·21 cites·16 claims
- 2174US6417330B1Insulin-like growth factor binding protein variantsCELTRIX PHARMA·Filed 1999·Granted Jul 9, 2002·22 cites·8 claims
- 2272US12410220B2Modulation of mammalian cell lineage by synthetic immodulinsMASCARENHAS DESMOND·Filed 2021·Granted Sep 9, 2025·0 cites·7 claims
- 2370US2024034761A1Regeneration of mammalian tissues using synthetic immodulinsMASCARENHAS DESMOND·Filed 2022·Application pending·0 cites
- 2468US6514937B1Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3CELTRIX PHARMA·Filed 1998·Granted Feb 4, 2003·24 cites·1 claims
- 2568US5629172AExpression of fusion polypeptides transported out of the cytoplasm without leader sequencesCELTRIX PHARMA·Filed 1994·Granted May 13, 1997·20 cites·23 claims
- 2666US6025368AMethod for treating the symptoms of chronic stress-related disorders using IGFCELTRIX PHARMA·Filed 1997·Granted Feb 15, 2000·29 cites·6 claims
- 2766US6025332AMethod for treating low circulating levels of sex hormone steroids associated with aging using IGF or IGF/IGFBP-3CELTRIX PHARMA·Filed 1998·Granted Feb 15, 2000·16 cites·3 claims
- 2864US7371813B2Method for use of IGF-binding protein for selective sensitization of target cells in vivoBIOEXPERTISE LLC·Filed 2004·Granted May 13, 2008·0 cites·2 claims
- 2963US2010152113A1Metal-binding therapeutic peptidesMASCARENHAS DESMOND·Filed 2009·Application pending·0 cites
- 3062US7058516B2Computer implemented searching using search criteria comprised of ratings prepared by leading practitioners in biomedical specialtiesBIOEXPERTISE INC·Filed 2001·Granted Jun 6, 2006·20 cites·5 claims
- 3162US2011202281A1Adaptive biochemical signaturesONTHERIX INC·Filed 2009·Application pending·0 cites
- 3259US2007141069A1Method for use of IGF-binding protein for selective sensitization of target cells in vivoINSMED INC·Filed 2007·Application pending·0 cites
- 3357US2003035788A1Method for use of IGF-binding protein for selective sensitization of target cells in vivoFiled 2001·Application pending·0 cites
- 3455US2013101970A1System and method for using psychological significance pattern information for matching with target informationPROTIGEN INC·Filed 2012·Application pending·0 cites
- 3555US2012041801A1System and method for using psychological significance pattern information for matching with target informationMASCARENHAS DESMOND·Filed 2011·Application pending·0 cites
- 3653US5459051AMethods and vectors for over-expression of ubiquitin fusion proteins in host cellsCELTRIX PHARMA·Filed 1993·Granted Oct 17, 1995·12 cites·18 claims
- 3752US12102685B2Immodulator peptides covalently modified with small moleculesMASCARENHAS DESMOND·Filed 2020·Granted Oct 1, 2024·0 cites·7 claims
- 3852US2007128113A1Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stressBIOEXPERTISE LLC·Filed 2006·Application pending·0 cites
- 3951US2002072589A1Insulin-like growth factor binding protein variantsCELTRIX PHARMA·Filed 2001·Application pending·0 cites
- 4050US2005209155A1IGF-binding protein-derived peptide or small moleculeBIOEXPERTISE LLC·Filed 2005·Application pending·0 cites
- 4149US2006161353A1Computer implemented searching using search criteria comprised of ratings prepared by leading practitioners in biomedical specialtiesBIOEXPERTISE INC·Filed 2006·Application pending·0 cites
- 4249US2006064322A1Online education resource for patients with metabolic syndromeMASCARENHAS DESMOND·Filed 2005·Application pending·0 cites
- 4349US2012252722A1Metal-binding therapeutic peptidesMASCARENHAS DESMOND·Filed 2011·Application pending·0 cites
- 4447US2005244422A1Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stressMASCARENHAS DESMOND·Filed 2005·Application pending·0 cites
- 4546US10369191B2Modulation of epigenetic stress responseMASCARENHAS DESMOND D·Filed 2016·Granted Aug 6, 2019·0 cites·11 claims
- 4646US6518238B1Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3CELTRIX PHARMA·Filed 1999·Granted Feb 11, 2003·4 cites·4 claims
- 4745US8536135B2Adaptive biochemical signaturesMASCARENHAS DESMOND·Filed 2011·Granted Sep 17, 2013·0 cites·9 claims
- 4844US2008039393A1Metal-binding therapeutic peptidesMASCARENHAS DESMOND·Filed 2007·Application pending·0 cites
- 4934US2016279186A1Modulation of epigenetic stress responseMASCARENHAS DESMOND D·Filed 2015·Application pending·0 cites
- 5032US7288516B1Null IGF for the treatment of cancerCELTRIX PHARMA·Filed 1999·Granted Oct 30, 2007·0 cites·39 claims
Join the waitlist — get patent alerts
Get an alert when Desmond Mascarenhas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →